CD8A and neoplasm: Using flow cytometry analysis, we thus evaluated the impact of SVX treatment on the frequencies and phenotypes of CD8+ T cells, CD4+ FoxP3− Tconv, and CD4+ FoxP3+ Treg cells both in the spleen and among tumor infiltrating lymphocytes (TILs) (Figures 6A,B) of TB mice vaccinated or not with SVX but also in TF mice.